Search News
| 60.87 Delayed Data As of 4:00pm ET |  +1.87 / +3.17%Today’s Change | 22.02 Today|||52-Week Range 111.36 | +1.93% Year-to-Date |
| Previous close | 59.00 |
| Today’s open | 58.41 |
| Day’s range | 58.30 - 62.70 |
| Volume | 2,979,268 |
| Average volume (3 months) | 3,581,546 |
| Market cap | $10.2B |
| Earnings growth (last year) | +43.64% |
| Earnings growth (this year) | +711.87% |
| Earnings growth (next 5 years) | -7.38% |
| Revenue growth (last year) | +86.00% |
| P/E ratio | 12.0 |
| Price/Sales | 30.27 |
| Price/Book | 107.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| NBIXNeurocrine Bioscienc... | +1.43 | +1.20% |
| EXASExact Sciences Corp | +2.46 | +3.22% |
| TLRYTilray Inc | -23.50 | -19.11% |
| BLUEbluebird bio Inc | -0.90 | -0.64% |
| Next reporting date | November 8, 2018 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $307.7M |
| Annual profit (last year) | -$96.7M |
| Net profit margin | -31.42% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Howard W. Robin |
Chief Operating Officer & Senior Vice President John Nicholson |
Corporate headquarters San Francisco, California |
